[go: up one dir, main page]

DK315889A - Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer. - Google Patents

Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer. Download PDF

Info

Publication number
DK315889A
DK315889A DK315889A DK315889A DK315889A DK 315889 A DK315889 A DK 315889A DK 315889 A DK315889 A DK 315889A DK 315889 A DK315889 A DK 315889A DK 315889 A DK315889 A DK 315889A
Authority
DK
Denmark
Prior art keywords
combinations
pharmaceutical preparations
antiviral
preparations containing
relationships used
Prior art date
Application number
DK315889A
Other languages
Danish (da)
English (en)
Other versions
DK315889D0 (da
Inventor
Todd Andrew Blumenkopf
Thomas Spector
Devron Randolph Averett
Jr Robert William Morrison
Eric Cleveland Bigham
Virgil Lee Styles
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK315889D0 publication Critical patent/DK315889D0/da
Publication of DK315889A publication Critical patent/DK315889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK315889A 1988-06-27 1989-06-26 Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer. DK315889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888815241A GB8815241D0 (en) 1988-06-27 1988-06-27 Antiviral combinations & compounds therefor

Publications (2)

Publication Number Publication Date
DK315889D0 DK315889D0 (da) 1989-06-26
DK315889A true DK315889A (da) 1989-12-28

Family

ID=10639423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315889A DK315889A (da) 1988-06-27 1989-06-26 Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.

Country Status (19)

Country Link
US (3) US5175165A (ko)
EP (1) EP0349243B1 (ko)
JP (1) JPH0245423A (ko)
KR (1) KR910000149A (ko)
AT (1) ATE74276T1 (ko)
AU (1) AU626304B2 (ko)
DE (1) DE68901111D1 (ko)
DK (1) DK315889A (ko)
ES (1) ES2031357T3 (ko)
FI (1) FI893112L (ko)
GB (1) GB8815241D0 (ko)
GR (1) GR3005067T3 (ko)
HU (1) HU206264B (ko)
IE (1) IE64496B1 (ko)
IL (1) IL90750A0 (ko)
MY (1) MY106304A (ko)
NZ (1) NZ229711A (ko)
PT (1) PT90972B (ko)
ZA (1) ZA894835B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
US5674849A (en) * 1990-10-24 1997-10-07 Allelix Biopharmaceuticals Inc. Anti-viral compositions
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
EP0746319A4 (en) * 1993-05-12 1997-11-05 Karl Y Hostetler ACYCLOVIR DERIVATIVES FOR TOPICAL USE
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
BR9609152A (pt) 1995-06-07 1999-05-04 Trimeris Inc Processo para tratamento de infecção por hiv em um individuo inibição da replicação do hiv e composição farmaceutica aceitavel util para o tratamento de infecção por hiv
US20030212051A1 (en) * 2001-04-06 2003-11-13 Polli James E Bile acid containing prodrugs with enhanced bioavailabilty
BRPI0510820A (pt) 2004-05-19 2007-11-27 Emisphere Tech Inc composição farmacêutica, forma unitária de dosagem e seus usos
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4777166A (en) * 1982-03-30 1988-10-11 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazone compositions as anitviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
GR3005067T3 (ko) 1993-05-24
FI893112A0 (fi) 1989-06-26
DK315889D0 (da) 1989-06-26
NZ229711A (en) 1992-08-26
ES2031357T3 (es) 1992-12-01
IE892060L (en) 1989-12-27
GB8815241D0 (en) 1988-08-03
AU3702689A (en) 1990-02-01
HUT52379A (en) 1990-07-28
IL90750A0 (en) 1990-01-18
EP0349243B1 (en) 1992-04-01
FI893112A7 (fi) 1989-12-28
AU626304B2 (en) 1992-07-30
EP0349243A2 (en) 1990-01-03
EP0349243A3 (en) 1990-07-11
US5393883A (en) 1995-02-28
IE64496B1 (en) 1995-08-09
ATE74276T1 (de) 1992-04-15
US5175165A (en) 1992-12-29
PT90972A (pt) 1989-12-29
HU206264B (en) 1992-10-28
PT90972B (pt) 1995-01-31
DE68901111D1 (de) 1992-05-07
MY106304A (en) 1995-04-29
ZA894835B (en) 1991-02-27
KR910000149A (ko) 1991-01-29
US5021437A (en) 1991-06-04
JPH0245423A (ja) 1990-02-15
FI893112L (fi) 1989-12-28

Similar Documents

Publication Publication Date Title
DK315889A (da) Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.
DK0686151T3 (da) Substituerede cycliske carbonylforbindelser og derivater deraf, der kan anvendes som retrovirale proteaseinhibitorer
NO306720B1 (no) Sykliske ureaer og analoger som er anvendbare som retrovirale proteaseinhibitorer, farmasöytiske preparater omfattende disse og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
EP0677048A1 (en) CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES.
ID1018B (id) N-tersier-butil-dekahidro-2(3-amino-2-hidroksi-4-fenil-butil) isokinolin-3-karboksamida dan turunan-turunan asparaginil darinya
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
MX9603909A (es) Derivados de sulfonamida como inhibidores de proteasa aspartilo.
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
BR9105737A (pt) Processo para reduzir a contaminacao de um produto de amplificacao,conjunto para uso em um tipo de procedimento de amplificacao e processo para amplificar uma sequencia de amplificacao de uma sequencia-alvo
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
MX9305766A (es) Procedimiento para la preparacion de derivados de taxano y productosobtenidos por medio del mismo.
FI935778A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av AIDS
ATE130315T1 (de) Hirudin-derivate mit verzögerter wirkung.
ES2102772T3 (es) Compuesto citotoxico y antiviral.
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
PT666755E (pt) Inibicao da infeccao pelo vih
ES2108254T3 (es) Composicion del inhibidor de infeccion con virus del sida.
IT1255728B (it) Derivati di s-triazina ad azione fotoprotettiva
NO922341L (no) Fremgangsmaate og middel for behandling av trombocytopeni

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment